Home
Inbox
Search
View Abstract
Content
Session(s)
A Randomized Controlled Trial of AZD7624, an Inhaled p38 MAP Kinase Inhibitor, in COPD Patients on ICS/LABA with a History of Frequent Exacerbations
Download
Send by Mail
View Handout
Home
Inbox
Search